The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Rebiopsy rate for non-small cell lung cancer patients after EGFR-TKI failure in clinical setting: Toward the third-generation EGFR-TKI era.
 
Takahisa Kawamura
No Relationships to Disclose
 
Hirotsugu Kenmotsu
No Relationships to Disclose
 
Kazushige Wakuda
No Relationships to Disclose
 
Akira Ono
No Relationships to Disclose
 
Tetsuhiko Taira
No Relationships to Disclose
 
Tateaki Naito
No Relationships to Disclose
 
Haruyasu Murakami
Consulting or Advisory Role - Astellas Pharma; Clovis Oncology
Speakers' Bureau - Boehringer Ingelheim; Chugai Pharma; Daiichi Sankyo; Nippon Kayaku; Pfizer; Taiho Pharmaceutical
Research Funding - Astellas Pharma (Inst); AstraZeneca (Inst); Chugai Pharma (Inst); Clovis Oncology (Inst); Kyowa Hakko Kirin (Inst); Lilly (Inst); Novartis (Inst); Quintiles (Inst); Taiho Pharmaceutical (Inst)
 
Yasuhisa Ohde
No Relationships to Disclose
 
Masahiro Endo
No Relationships to Disclose
 
Toshiaki Takahashi
Speakers' Bureau - AstraZeneca; Lilly; Ono Pharmaceutical